Ledger.Open graph →
SEC Form D · filed October 16, 2025

SightStream Biotherapeutics, Inc

Offering
$1.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALPOLE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Wenkai Xiang · Walpole, MADirectorDavid Neafus · Cambridge, MAExecReza Dana · Newton, MADirectorJason Werner · Fort Worth, TXExec · DirectorSamuel Wu · Foster City, CADirectorReza Dana · Newton, MADirectorSamuel Wu · Walpole, MADirectorWenkai Xiang · Walpole, MADirectorDavid Neafus · Cambridge, MAExecReza Dana · Newton, MADirectorJason Werner · Fort Worth, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗